382 



Mr. Glenn, I don't know why they chose to do that, Mr. Wax- 

 man. 



Mr. Waxman. Why would CTR want to cooperate? 



Let me read to you from the Los Angeles Times of today; in 1978 

 memos to top B&W executives — they were told that CTR solved a 

 huge legal quandary involving the industries' need to both fund re- 

 search and be able to dismiss adverse findings, and they are avoid- 

 ing this research dilemma to a responsible manufacturer of ciga- 

 rettes which on the one hand needs to know the state of the art 

 and on the other hand cannot afford the risk of having in-house 

 work turn sour. 



The point here is the value of having CTR doing work in a 

 nondirected and independent fashion as contracted work either in- 

 house or under B&W contract which if it goes wrong can become 

 the smoking pistol in a lawsuit. 



So this seems to indicate that the companies used you or your 

 organization as a way to have a deniability for that research which 

 could come back to haunt them in lawsuits. Is that an accurate 

 statement? 



Mr. Glenn. I don't think so. The nuances escape me a little bit. 

 But let me put it to you this way. Any time the CTR served as the 

 administrative agent for special projects, we informed the recipient 

 of those funds that should they publish they should acknowledge 

 that this was a special project funded through the Council for To- 

 bacco Research. 



That tag line appeared on their publications so it was different 

 from a research grant. This was — this was essentially contract 

 work and we served as the funding agent only. 



Mr. Waxman. Why wouldn't they acknowledge on their document 

 that the company actually funded them? 



Mr. Glenn. In many instances as I understand it — this is before 

 my time — several of the companies might have joined in funding a 

 specific project. We were the funding agency. 



Mr. Waxman. What I read to you from the LA Times was a 

 memo from the general counsel of Brown & Williamson explaining 

 that this is what they were doing, they are trying to get by this 

 legal quandary. 



Mr. Glenn. I can't respond to that. I have just seen the memo- 

 randum — the article. 



Mr. Waxman. Why don't you look it over. We are going to have 

 to take a break, you may have heard the bells ring, to respond to 

 a vote on the House Floor. We will do that and return as quickly 

 as possible to continue our inquiries. 



[Brief recess]. 



Mr. Synar [presiding]. Doctor, if you could join us at the table 

 again, please. 



The Chair recognizes the gentleman from Virginia for questions. 



Mr. Bliley. Thank you. 



Dr. Glenn, why did the companies not conduct special project re- 

 search in-house, do you know? 



Mr. Glenn. No, sir, I don't know. 



Mr. Synar. Hit your microphone, Doctor, so we can hear you. 



Mr. Glenn. No, sir, I don't know. 



